Zantac Recall: What You Should Know
In September of 2019, the US Food and Drug Administration announced that low levels of N-nitrosodimethylamine (NDMA) had been detected in Zantac. NDMA is a carcinogen and has been found in several other drugs over the years. More recently, even highe...